CERT 8-K SEC Filing Analysis

Latest settled — T+5d ⚠ clustered

CERT ▼ -11.11% at T+5d

SHORT call ✓ call won +11.11% · α vs SPY +11.03% · entry $5.13 → $4.56

Next anchor: T+20d due 17h ago

Last close $5.22 (close Jun 8) · -1.75% from $5.13 entry (call sign-flipped)

Entry anchored
May 11, 2026
via day open

T+1d

-0.78%

call +0.78% · α +0.64%

$5.09

settled 29d ago

T+5d

-11.11%

call +11.11% · α +11.03%

$4.56

settled 23d ago

T+20d

—

call — · α —

—

due 17h ago

T+60d

—

call — · α —

—

in 8w

Price Chart

Loading chart...

Executive Summary

Certara reported Q1 2026 revenue of $106.9M (+1% YoY), but GAAP net loss widened to $8.8M from +$4.7M and adjusted diluted EPS fell to $0.09 from $0.14. FY2026 guidance was lowered significantly: revenue $395M-$405M (including ~$18M from divested business) and adjusted EPS $0.35-$0.41 (down from prior $0.44-$0.48). The company completed the $85M divestiture of its medical writing business on May 8, 2026. The combination of declining profitability, lowered guidance, and a shrinking revenue base drives a bearish read.

Key Financial Metrics

Guidance

$395M-$405M

lowered

Actionable Insight

The lowered guidance and earnings deterioration signal near-term headwinds. Monitor Q2 for software bookings momentum and execution on divestiture proceeds. The stock may face pressure as the market reacts to the guidance cut and declining profitability.

Key Facts

Q1 2026 revenue $106.9M (+1% YoY); software +7%, services -4%
GAAP net loss $8.8M vs net income of $4.7M in Q1 2025
Adjusted diluted EPS $0.09 vs $0.14 prior year (consensus $0.07, beat 29%)
Adjusted EBITDA $31.7M, down 9% from $34.8M
FY2026 guidance lowered: revenue $395M-$405M, adjusted EPS $0.35-$0.41
Completed sale of medical writing business for $85M cash plus up to $50M earn-out

Financial Impact

Guidance for adjusted EPS cut ~17% from prior midpoint of $0.46; revenue guidance implies ~5% decline from FY2025 actual of $418.8M including $18M from divested business

revenueepsebitdanet income

Risk Factors

Services revenue continued to decline (-4% YoY) with bookings down 14%
Execution risk from divestiture and reorganization
Macro/biotech funding headwinds could further pressure spending

Market Snapshot

Exchange

Nasdaq

Sector

Services-Prepackaged Software

Analyst Consensus

55% bullish (20 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001827090-26-000017
Document: certara-20260511.htm	0001827090-26-000017
Document: 0001827090-26-000017-index-headers.html	0001827090-26-000017
Document: 0001827090-26-000017-index.html	0001827090-26-000017
Document: 0001827090-26-000017.txt	0001827090-26-000017
8-K Data (Synthetic)	0001827090-26-000017

7 reports for CERT

T+1T+5T+20T+60

67% Hit rate 2 of 3 directional calls best @ T+5▲ +11.11%May 11, 2026

Filters

Reports for CERT — sortable, filterable
	Type				Now
May 11, 2026 29d ago	8-K BEARISH ★ 6/10	$5.13 $4.56	▲ +11.11%	▲ +11.03%	$5.22 (−1.75%)
May 11, 2026 29d ago	Press Release BEARISH ★ 7/10	$5.13 $4.56	▲ +11.11%	▲ +11.03%	$5.22 (−1.75%)
Apr 22, 2026 6w ago	8-K / PRESS-RELEASE BULLISH ★ 7/10	$6.38 $6.11	▼ −4.23%	▼ −4.29%	$5.22 (−18.18%)
Apr 3, 2026 9w ago	DEFA14A NEUTRAL ★ 4/10	$5.46 $5.79	▲ +6.04%	▲ +1.91%	$5.22 (−4.40%)
Mar 30, 2026 10w ago	Court Ruling NEUTRAL ★ 3/10	$5.68 $5.62	▼ −1.06%	▼ −5.36%	$5.22 (−8.10%)
Mar 3, 2026 14w ago	Press Release BULLISH ★ 8/10	$7.24 $6.93	▼ −4.28%	▼ −3.80%	$5.22 (−27.90%)
Feb 26, 2026 14w ago	8-K MIXED ★ 6/10	$6.80 $7.15	▲ +5.15%	▲ +6.27%	$5.22 (−23.24%)

US Market Status

Market Closed — Opens in 8h 36m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access